• All sections
  • A - Human necessities
  • A61K - Preparations for medical, dental or toiletry purposes
  • A61K 47/60 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol

Patent holdings for IPC class A61K 47/60

Total number of patents in this class: 4106

10-year publication summary

249
392
475
459
495
476
453
427
349
182
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Nektar Therapeutics
402
85
Hanmi Pharm. Co., Ltd.
601
71
The Regents of the University of California
20745
66
Ascendis Pharma A/S
195
48
Bristol-myers Squibb Company
4742
47
The Johns Hopkins University
5882
44
Ascendis Pharma Growth Disorders A/S
61
43
Massachusetts Institute of Technology
10251
39
Board of Regents, The University of Texas System
6107
34
Ascendis Pharma Bone Diseases A/S
56
30
Amgen Inc.
4427
26
Apellis Pharmaceuticals, Inc.
136
26
Northwestern University
3543
25
NOK Corporation
2299
24
ProLynx LLC
60
24
Janssen Pharmaceutica N.V.
3168
23
Quiapeg Pharmaceuticals AB
38
22
Synthorx, Inc.
48
22
The Board of Trustees of the Leland Stanford Junior University
6653
21
The University of Tokyo
4361
21
Other owners 3365